Premarket Mover: Processa Pharmaceuticals Inc (PCSA) Up 2.59%

Processa Pharmaceuticals Inc (PCSA) is higher by Wednesday morning, with the stock rising 2.59% in pre-market trading to 2.38. PCSA's short-term technical score of 11 indicates that the stock has traded less bullishly over the last month than 89% of stocks on the market. In the Biotechnology industry, which ranks 85 out of 146 industries, PCSA ranks higher than 18% of stocks. Processa Pharmaceuticals Inc has fallen 36.78% over the past month, closing at $2.36 on January 31. During this period of time, the stock fell as low as $2.12 and as high as $2.73. PCSA has an average analyst recommendation of Buy. The company has an average price target of $80.00.

PCSA has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on PCSA!

See Full PCSA Report

Processa Pharmaceuticals Inc has a Long-Term Technical rank of 17. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 83% of the market scoring higher. In the Biotechnology industry which is number 47 by this metric, PCSA ranks better than 47% of stocks.

Important Dates for Investors in PCSA:

-Processa Pharmaceuticals Inc is set to release earnings on 2024-04-04. Over the last 12 months, the company has reported EPS of $-22.80. -We do not have a set dividend date for Processa Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Processa Pharmaceuticals Inc (PCSA)